性激素结合球蛋白
痴呆
危险系数
医学
入射(几何)
睾酮(贴片)
比例危险模型
内科学
前瞻性队列研究
队列
队列研究
内分泌学
置信区间
疾病
雄激素
激素
物理
光学
作者
Ross J. Marriott,Kevin Murray,Leon Flicker,Graeme J. Hankey,Alvin M. Matsumoto,Girish Dwivedi,Antonio L’Abbate,Osvaldo P. Almeida,Shalender Bhasin,Adrian S. Dobs,David J. Handelsman,R. Häring,Terence W O’Neill,Claes Ohlsson,Eric S. Orwoll,Dirk Vanderschueren,Gary Wittert,Frederick C. W. Wu,Bu B. Yeap
摘要
Abstract Introduction The association of testosterone concentrations with dementia risk remains uncertain. We examined associations of serum testosterone and sex hormone–binding globulin (SHBG) with incidence of dementia and Alzheimer's disease. Methods Serum total testosterone and SHBG were measured by immunoassay. The incidence of dementia and Alzheimer's disease (AD) was recorded. Cox proportional hazards regression was adjusted for age and other variables. Results In 159,411 community‐dwelling men (median age 61, followed for 7 years), 826 developed dementia, including 288 from AD. Lower total testosterone was associated with a higher incidence of dementia (overall trend: P = .001, lowest vs highest quintile: hazard ratio [HR] = 1.43, 95% confidence interval [CI] = 1.13‐1.81), and AD ( P = .017, HR = 1.80, CI = 1.21‐2.66). Lower SHBG was associated with a lower incidence of dementia ( P < .001, HR = 0.66, CI = 0.51‐0.85) and AD ( P = .012, HR = 0.53, CI = 0.34‐0.84). Discussion Lower total testosterone and higher SHBG are independently associated with incident dementia and AD in older men. Additional research is needed to determine causality.
科研通智能强力驱动
Strongly Powered by AbleSci AI